Compare MAGN & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MAGN | UROY |
|---|---|---|
| Founded | 1864 | 2017 |
| Country | United States | Canada |
| Employees | 2980 | N/A |
| Industry | Paper | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 448.6M | 404.6M |
| IPO Year | 1994 | 2026 |
| Metric | MAGN | UROY |
|---|---|---|
| Price | $12.00 | $4.16 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 436.6K | ★ 3.5M |
| Earning Date | 05-07-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,204,000,000.00 | N/A |
| Revenue This Year | $5.37 | $279.20 |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | ★ N/A | $1,584.46 |
| Revenue Growth | ★ 46.50 | N/A |
| 52 Week Low | $7.82 | $2.51 |
| 52 Week High | $15.52 | $5.52 |
| Indicator | MAGN | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 72.19 |
| Support Level | $11.55 | $3.40 |
| Resistance Level | $15.03 | $4.48 |
| Average True Range (ATR) | 0.60 | 0.27 |
| MACD | -0.20 | 0.07 |
| Stochastic Oscillator | 12.71 | 91.22 |
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.